Uploaded February 2023 | Updated September 2026, 2 weeks ago
Dr. Mehta is the Principal Investigator for the United States congressionally-mandated National Amyotrophic Lateral Sclerosis (ALS) Registry which resides within the Centers for Disease Control and Prevention and is responsible for providing medical, scientific, and epidemiological expertise on matters related to ALS. He has been in this role since 2013. Prior to joining ATSDR, Dr. Mehta was responsible for overseeing external research initiatives for the National Center for Environmental Health (NCEH) and ATSDR. Dr. Mehta started his career at CDC as a Team Leader for the Division of Select Agents and Toxins (DSAT) where he was responsible for CDC’s Etiological Agent Import Permit Program (EAIPP) as well as conducting audits of high containment laboratories nationally. Dr. Mehta has a Doctor of Medicine (MD) from the Fatima Medical Science Foundation and a Bachelor of Arts in Biology from the University of Toledo.
Dr. Mehta is the Principal Investigator for the United States congressionally-mandated National Amyotrophic Lateral Sclerosis (ALS) Registry which resides within the Centers for Disease Control and Prevention and is responsible for providing medical, scientific, and epidemiological expertise on matters related to ALS. He has been in this role since 2013. Prior to joining ATSDR, Dr. Mehta was responsible for overseeing external research initiatives for the National Center for Environmental Health (NCEH) and ATSDR. Dr. Mehta started his career at CDC as a Team Leader for the Division of Select Agents and Toxins (DSAT) where he was responsible for CDC’s Etiological Agent Import Permit Program (EAIPP) as well as conducting audits of high containment laboratories nationally. Dr. Mehta has a Doctor of Medicine (MD) from the Fatima Medical Science Foundation and a Bachelor of Arts in Biology from the University of Toledo.
